The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Venofer (Iron Sucrose Injection) Market Research Report 2025
Synopsis
Venofer® (iron sucrose injection, USP) provides first-line IV iron therapy for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 2 years and older with chronic kidney disease (CKD).
The global Venofer (Iron Sucrose Injection) market was valued at US$ 110 million in 2023 and is anticipated to reach US$ 174.9 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Venofer (Iron Sucrose Injection) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Venofer (Iron Sucrose Injection) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Venofer (Iron Sucrose Injection) include Luitpold Pharmaceuticals. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Venofer (Iron Sucrose Injection), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venofer (Iron Sucrose Injection).
Report Scope
The Venofer (Iron Sucrose Injection) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Venofer (Iron Sucrose Injection) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venofer (Iron Sucrose Injection) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luitpold Pharmaceuticals
Segment by Type
50 mg/2.5 mL
100 mg/5 mL
200 mg/10 mL
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Venofer (Iron Sucrose Injection) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Venofer (Iron Sucrose Injection) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Venofer® (iron sucrose injection, USP) provides first-line IV iron therapy for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 2 years and older with chronic kidney disease (CKD).
The global Venofer (Iron Sucrose Injection) market was valued at US$ 110 million in 2023 and is anticipated to reach US$ 174.9 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Venofer (Iron Sucrose Injection) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Venofer (Iron Sucrose Injection) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Venofer (Iron Sucrose Injection) include Luitpold Pharmaceuticals. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Venofer (Iron Sucrose Injection), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venofer (Iron Sucrose Injection).
Report Scope
The Venofer (Iron Sucrose Injection) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Venofer (Iron Sucrose Injection) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venofer (Iron Sucrose Injection) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luitpold Pharmaceuticals
Segment by Type
50 mg/2.5 mL
100 mg/5 mL
200 mg/10 mL
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Venofer (Iron Sucrose Injection) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Venofer (Iron Sucrose Injection) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Venofer (Iron Sucrose Injection) Market Overview
1.1 Product Overview and Scope of Venofer (Iron Sucrose Injection)
1.2 Venofer (Iron Sucrose Injection) Segment by Type
1.2.1 Global Venofer (Iron Sucrose Injection) Market Value Comparison by Type (2024-2030)
1.2.2 50 mg/2.5 mL
1.2.3 100 mg/5 mL
1.2.4 200 mg/10 mL
1.3 Venofer (Iron Sucrose Injection) Segment by Application
1.3.1 Global Venofer (Iron Sucrose Injection) Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Venofer (Iron Sucrose Injection) Market Size Estimates and Forecasts
1.4.1 Global Venofer (Iron Sucrose Injection) Revenue 2019-2030
1.4.2 Global Venofer (Iron Sucrose Injection) Sales 2019-2030
1.4.3 Global Venofer (Iron Sucrose Injection) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Venofer (Iron Sucrose Injection) Market Competition by Manufacturers
2.1 Global Venofer (Iron Sucrose Injection) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Venofer (Iron Sucrose Injection) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Venofer (Iron Sucrose Injection) Average Price by Manufacturers (2019-2024)
2.4 Global Venofer (Iron Sucrose Injection) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Venofer (Iron Sucrose Injection), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venofer (Iron Sucrose Injection), Product Type & Application
2.7 Venofer (Iron Sucrose Injection) Market Competitive Situation and Trends
2.7.1 Venofer (Iron Sucrose Injection) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Venofer (Iron Sucrose Injection) Players Market Share by Revenue
2.7.3 Global Venofer (Iron Sucrose Injection) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Venofer (Iron Sucrose Injection) Retrospective Market Scenario by Region
3.1 Global Venofer (Iron Sucrose Injection) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Venofer (Iron Sucrose Injection) Global Venofer (Iron Sucrose Injection) Sales by Region: 2019-2030
3.2.1 Global Venofer (Iron Sucrose Injection) Sales by Region: 2019-2024
3.2.2 Global Venofer (Iron Sucrose Injection) Sales by Region: 2025-2030
3.3 Global Venofer (Iron Sucrose Injection) Global Venofer (Iron Sucrose Injection) Revenue by Region: 2019-2030
3.3.1 Global Venofer (Iron Sucrose Injection) Revenue by Region: 2019-2024
3.3.2 Global Venofer (Iron Sucrose Injection) Revenue by Region: 2025-2030
3.4 North America Venofer (Iron Sucrose Injection) Market Facts & Figures by Country
3.4.1 North America Venofer (Iron Sucrose Injection) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Venofer (Iron Sucrose Injection) Sales by Country (2019-2030)
3.4.3 North America Venofer (Iron Sucrose Injection) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Venofer (Iron Sucrose Injection) Market Facts & Figures by Country
3.5.1 Europe Venofer (Iron Sucrose Injection) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Venofer (Iron Sucrose Injection) Sales by Country (2019-2030)
3.5.3 Europe Venofer (Iron Sucrose Injection) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venofer (Iron Sucrose Injection) Market Facts & Figures by Country
3.6.1 Asia Pacific Venofer (Iron Sucrose Injection) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Venofer (Iron Sucrose Injection) Sales by Country (2019-2030)
3.6.3 Asia Pacific Venofer (Iron Sucrose Injection) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Venofer (Iron Sucrose Injection) Market Facts & Figures by Country
3.7.1 Latin America Venofer (Iron Sucrose Injection) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Venofer (Iron Sucrose Injection) Sales by Country (2019-2030)
3.7.3 Latin America Venofer (Iron Sucrose Injection) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venofer (Iron Sucrose Injection) Market Facts & Figures by Country
3.8.1 Middle East and Africa Venofer (Iron Sucrose Injection) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Venofer (Iron Sucrose Injection) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Venofer (Iron Sucrose Injection) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Venofer (Iron Sucrose Injection) Sales by Type (2019-2030)
4.1.1 Global Venofer (Iron Sucrose Injection) Sales by Type (2019-2024)
4.1.2 Global Venofer (Iron Sucrose Injection) Sales by Type (2025-2030)
4.1.3 Global Venofer (Iron Sucrose Injection) Sales Market Share by Type (2019-2030)
4.2 Global Venofer (Iron Sucrose Injection) Revenue by Type (2019-2030)
4.2.1 Global Venofer (Iron Sucrose Injection) Revenue by Type (2019-2024)
4.2.2 Global Venofer (Iron Sucrose Injection) Revenue by Type (2025-2030)
4.2.3 Global Venofer (Iron Sucrose Injection) Revenue Market Share by Type (2019-2030)
4.3 Global Venofer (Iron Sucrose Injection) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Venofer (Iron Sucrose Injection) Sales by Application (2019-2030)
5.1.1 Global Venofer (Iron Sucrose Injection) Sales by Application (2019-2024)
5.1.2 Global Venofer (Iron Sucrose Injection) Sales by Application (2025-2030)
5.1.3 Global Venofer (Iron Sucrose Injection) Sales Market Share by Application (2019-2030)
5.2 Global Venofer (Iron Sucrose Injection) Revenue by Application (2019-2030)
5.2.1 Global Venofer (Iron Sucrose Injection) Revenue by Application (2019-2024)
5.2.2 Global Venofer (Iron Sucrose Injection) Revenue by Application (2025-2030)
5.2.3 Global Venofer (Iron Sucrose Injection) Revenue Market Share by Application (2019-2030)
5.3 Global Venofer (Iron Sucrose Injection) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Luitpold Pharmaceuticals
6.1.1 Luitpold Pharmaceuticals Corporation Information
6.1.2 Luitpold Pharmaceuticals Description and Business Overview
6.1.3 Luitpold Pharmaceuticals Venofer (Iron Sucrose Injection) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Luitpold Pharmaceuticals Venofer (Iron Sucrose Injection) Product Portfolio
6.1.5 Luitpold Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venofer (Iron Sucrose Injection) Industry Chain Analysis
7.2 Venofer (Iron Sucrose Injection) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venofer (Iron Sucrose Injection) Production Mode & Process
7.4 Venofer (Iron Sucrose Injection) Sales and Marketing
7.4.1 Venofer (Iron Sucrose Injection) Sales Channels
7.4.2 Venofer (Iron Sucrose Injection) Distributors
7.5 Venofer (Iron Sucrose Injection) Customers
8 Venofer (Iron Sucrose Injection) Market Dynamics
8.1 Venofer (Iron Sucrose Injection) Industry Trends
8.2 Venofer (Iron Sucrose Injection) Market Drivers
8.3 Venofer (Iron Sucrose Injection) Market Challenges
8.4 Venofer (Iron Sucrose Injection) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
